Below are a variety of abstracts from the 2004 ASCO convention, and the 2003 ASH convention which give compelling evidence that Rituxan in combination with chemotherapy can increase the rate of cures for aggressive types of non-hodgkin's lymphoma, and extend the Time To Progression for follicular and other types of low grade lymphoma.
Author(s): K. S. Wilson, L. H. Sehn, B. Berry, M. Chhanabhai, J. M. Connors, C. A. Fitzgerald, K. K. Gill, R. Klasa, B. Skinnider, R. D. Gascoyne; BC Cancer Agency, Victoria, BC, Canada; BC Cancer Agency, Vancouver, BC, Canada; BC Cancer Agency, Surrey, BC, Canada
Author(s): W. Hiddemann, M. Dreyling, M. Unterhalt, R. Repp, S. Hermann, A. Haenel, B. Metzner, C. Pott, F. Hartmann, R. Parwaresch; Ludwig-Maximilians-University, München, Germany
Author(s): M. G. Pfreundschuh, L. Trümper, D. Ma, A. Österborg, R. Pettengell, M. Trneny, L. Shepherd, J. Waleswski, P.-L. Zinzani, M. Loeffler; Saarland University Medical School, Homburg, Germany; DSHNHL, Homburg, Germany; Australasian Leukaemia and Lymphoma Group ALLG, Sidney, Australia; Swedish Lymphoma Group, Stockholm, Sweden; Britsih National Lymphoma Investigation, London, United Kingdom; Charles University, Prague, Czech Republic; NCI-Canada Lymphoma Group, Homburg, Germany; Polish Lymphoma Group, Warszawa, Poland; Italian Northern Lymphoma Group, Bologna, Italy
Author(s): K. Tobinai, T. Watanabe, M. Ogura, Y. Morishima, K. Itoh, T. Igarashi, T. Hotta, T. Kinoshita, S. Mori, Y. Ohashi; National Cancer Center Hospital, Tokyo, Japan; Aichi Cancer Center, Nagoya, Japan; National Cancer Center Hospital East, Kashiwa, Japan; Tokai University, Isehara, Japan; Nagoya University, Nagoya, Japan; University of Tokyo, Tokyo, Japan
Author(s): H. S. Hochster, E. Weller, T. Ryan, T. M. Habermann, R. Gascoyne, S. R. Frankel, S. J. Horning, Eastern Cooperative Oncology Group, Cancer and Leukemia Group B; NYU School of Medicine, New York, NY; DFCI, Boston, MA; Mayo Clinic, Rochester, MN; British Cancer Control Agency, Vancouver, BC, Canada; University of Maryland, Baltimore, MD; Stanford School of Medicine, Stanford, CA
Wolfgang Hiddemann, Martin H. Dreyling, Roswitha Forstpointner, Michael Kneba, Bernhard Woermann, Eva Lengfelder, Rudolf Schmits, Marcel Reiser, Bernd Metzner, Norbert Schmitz, Lorenz Truemper, H. Eimermacher, Reza Parwaresch Department of Internal Medicine III, University of Munich - Hospital Grosshadern, Munich, Germany; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany; Department of Internal Medicine, Hospital Braunschweig, Braunschweig, Germany; Department of Internal Medicine III, University of Heidelberg - Hospital Mannheim, Mannheim, Germany; Department of Internal Medicine I, University Hospital Homburg/Saar, Homburg, Germany; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany; Department of Internal Medicine II, Hospital Oldenburg, Oldenburg, Germany; Department of Internal Medicine, St. Georg Hospital, Hamburg, Germany; Department of Internal Medicine, University Hospital Goettingen, Goettingen, Germany; Department of Medicine, St Marien Hospital, Hagen, Germany; Department of Hematopathology, University Hospital Schleswig-Holstein, Kiel, Germany